Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Fischer Medical Ventures Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Fischer Medical Ventures Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Fischer Medical Vent - Audited Results For The Year 31.03.2025

    30 May 2025, 8:43PM Audited Results for the year 31.03.2025
  • Fischer Medical Vent posts Q4 net loss of Rs 0.89 cr

    29 May 2025, 1:44PM The company reported standalone net loss during the quarter stood at Rs 0.89 crore compared to net profit of Rs 0.60 crore in the previous year quarte
  • Fischer Medical Vent - Board Meeting Intimation for Consideration And Approval Of Audited Financial Results For The Year And

    22 May 2025, 4:52PM Fischer Medical Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 ,inter alia, to cons
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

    16 May 2025, 7:39PM Fischer Medical Ventures Limited has informed the exchange on the receipt of Monitoring agency report for the quarter ended 31.03.2025
  • Fischer Medical Vent has submitted to BSE the Shareholding Pattern for the Period Ended April 09, 2025

    10 May 2025, 10:51AM As of April 2025, 61.80% is owned by Promoters and 38.20% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 10.64% and Fore
  • Fischer Medical Vent - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    5 May 2025, 2:30PM Fischer Medical Ventures Limited has informed the exchange on the outcome of Postal ballot and the scrutinizer report
  • Fischer Medical Vent - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

    30 Apr 2025, 3:52PM <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'><tr> <td><b>Sr. No.</b></td
  • Fischer Medical Vent - Announcement Under Regulation 30

    23 Apr 2025, 4:22PM Intimation by Material Subsidiary on the Investment
  • Fischer Medical Vent - Announcement Under Regulation 30 - Intimation Of Receipt Of Central Government Approval

    23 Apr 2025, 3:37PM Fischer Medical Ventures Ltd has informed the exchange on receipt of Central Government Approval for appointment of Managing Director
  • Fischer Medical Vent - Announcement Under Regulation 30

    21 Apr 2025, 8:58PM Update from Material Subsidiary on its proposed investment
  • Fischer Medical Vent - Announcement Under Regulation 30

    21 Apr 2025, 8:55PM Fischer Medical Ventures Limited has informed the exchange on approval for proposed investment as detailed in the annexures to this announcement
  • Fischer Medical Vent - General Update

    10 Apr 2025, 2:42PM Please find attached file
  • Fischer Medical Vent - Update On Allotment Of ISIN

    9 Apr 2025, 7:04PM Fischer Medical Ventures Limited (formerly known as Fischer Chemic Limited) has informed the exchange on creation of ISIN with NSDL
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Allotment

    9 Apr 2025, 6:30PM Fischer Medical Ventures Limited has allotted 10,50,000 equity shares upon conversion of convertible warrants issued on a preferential basis to non-pr
  • Fischer Medical Vent has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    9 Apr 2025, 3:00PM As of March 2025, 62.81% is owned by Promoters and 37.19% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 10.82% and Fore
  • Fischer Medical Vent - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    9 Apr 2025, 2:01PM Fischer Medical Ventures Limited (formerly known as Fischer Chemic Limited) has informed the exchange on the compliance of Certificate under Regulatio
  • Fischer Medical Vent - Intimation About Investment By Material Subsidiary

    7 Apr 2025, 7:01PM Intimation about Investment in Material Subsidiary
  • Fischer Medical Vent - Postal Ballot Notice Intimation

    4 Apr 2025, 1:44PM Fischer Medical Ventures Limited (formerly known as Fischer Chemic Limited) has informed the exchange on intimation of Postal Ballot Notice

Key fundamentals

Evaluate the intrinsic value of Fischer Medical Ventures Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 335.6851 79.6794 0.3057 0.1597 0.2359
Liabilities 335.6851 79.6794 0.3057 0.1597 0.2359
Equity 63.8015 53.5 0.172 0.172 0.172
Gross Profit -2.2373 -0.1952 0.0152 -0.1887 -0.1825
Net Profit 0.6632 0.4028 -0.0365 -0.2326 0.1406
Cash From Operating Activities -22.8064 0.0796 -0.1459 -0.1769 -0.0573
NPM(%) 12.7 3.49 -20.33 0 0
Revenue 5.2197 11.5283 0.1795 0 0
Expenses 7.457 11.7235 0.1643 0.1887 0.1825
ROE(%) 0.73 0.44 -0.04 -0.25 0.15

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Fischer Medical Ventures Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Nitta Gelatin India Ltd 820.10 -0.67 8.87 806.69 924.57 0.98
Sharda Cropchem Ltd 805.00 -0.79 23.87 8016.09 337.37 1.12
Ram Minerals and Chemicals Ltd 0.49 0.00 49.00 18284.45 -0.09 0.00
Amines and Plasticizers Ltd 244.80 -0.29 33.22 4888.53 372.61 0.20

Company Info

The Company was incorporated as a Public Limited Company on 22nd March 1993, and obtained certificate of commencement of business on 19th August 1993. The Company entered into an agreement with the Partnership firm M/s. Fischer Inorganics & Aromatics, Madras to take over the partnership business as a going concern without any break as per the agreement dated 19th January 1994. To fully exploit the vast potential and growth prospects available for the various grades of laboratory chemicals particularly after the delicensing of the industry,the promoters have thought fit to put up a larger capacity project so as to achieve the economies of scale of production and marketing. The partnership firm has been engaged in the Processing/Manufacturing of Laboratory Grade Chemicals, for about 10 years. PRESENT BUSINESS The Company is already engaged in the manufacture of certain grades of Laboratory Chemicals in its plant situated at Aminjikarai and Palavakkam, near Madras city (taken over from the partnership firm M/s Fischer Inorganics and Aromatics). These Grades of Laboratory Chemicals are broadly clasified as SALTS, SOLVENTS & ACIDS which include 1. Laboratory & Analytical Reagent Grade Chemicals (LR & AR Grade) used in QC/R & D Lab. of Industries / Institutions 2. Electronic Reagent Grade Chemicals (EL Grade) used in the Process of both Manufacturing & Assembling Electronic Industries. 3. IP Grade Chemicals used in Pharmaceutical Industries. 4. Diagnostic Grade Chemicals used in Hospitals/Clinical Laboratories for either Bio-Chemical or Histopathological Estimations. 2003 -Fischer Chem gets ISO 9001:2000 certification by M/s. RWTUV of Germany 2008 -Fischer Chemic has designated E-mail ID for Investors Complaints: fischerlab@vsnl.net 2013 -Company has changed its Registered Office from No. 3/240, Govindan Nagar, Palavakkam, Chennai - 600041, Tamilnadu to First Floor, Silver Sky Super Market Complex, New No. 15 Gangai Amman Koil Street, Kodambakkam, Chennai - 600 024, Tamilnadu.

The Company was incorporated as a Public Limited Company on 22nd March 1993, and obtained certificate of commencement of business on 19th August 1993. The Company entered into an agreement with the Partnership firm M/s. Fischer Inorganics & Aromatics, Madras to take over the partnership business as a going concern without any break as per the agreement dated 19th January 1994. To fully exploit the vast potential and growth prospects available for the various grades of laboratory chemicals particularly after the delicensing of the industry,the promoters have thought fit to put up a larger capacity project so as to achieve the economies of scale of production and marketing. The partnership firm has been engaged in the Processing/Manufacturing of Laboratory Grade Chemicals, for about 10 years. PRESENT BUSINESS The Company is already engaged in the manufacture of certain grades of Laboratory Chemicals in its plant situated at Aminjikarai and Palavakkam, near Madras city (taken over from the partnership firm M/s Fischer Inorganics and Aromatics). These Grades of Laboratory Chemicals are broadly clasified as SALTS, SOLVENTS & ACIDS which include 1. Laboratory & Analytical Reagent Grade Chemicals (LR & AR Grade) used in QC/R & D Lab. of Industries / Institutions 2. Electronic Reagent Grade Chemicals (EL Grade) used in the Process of both Manufacturing & Assembling Electronic Industries. 3. IP Grade Chemicals used in Pharmaceutical Industries. 4. Diagnostic Grade Chemicals used in Hospitals/Clinical Laboratories for either Bio-Chemical or Histopathological Estimations. 2003 -Fischer Chem gets ISO 9001:2000 certification by M/s. RWTUV of Germany 2008 -Fischer Chemic has designated E-mail ID for Investors Complaints: fischerlab@vsnl.net 2013 -Company has changed its Registered Office from No. 3/240, Govindan Nagar, Palavakkam, Chennai - 600041, Tamilnadu to First Floor, Silver Sky Super Market Complex, New No. 15 Gangai Amman Koil Street, Kodambakkam, Chennai - 600 024, Tamilnadu.

Read More

Parent Organisation

Fischer Medical Ventures Ltd.

Founded

22/03/1993

Managing Director

Mr.Ravindran Govindan

NSE Symbol

FAQ

The current price of Fischer Medical Ventures Ltd is

The 52-week high for Fischer Medical Ventures Ltd is

The market capitalization of Fischer Medical Ventures Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Fischer Medical Ventures Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Fischer Medical Ventures Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Fischer Medical Ventures Ltd shares.

The CEO of Fischer Medical Ventures Ltd is Mr.Ravindran Govindan, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT